» Articles » PMID: 32999601

Breaking Down Barriers and Binaries in Trans Healthcare: the Validation of Non-binary People

Overview
Journal Int J Transgend
Date 2020 Oct 1
PMID 32999601
Citations 11
Authors
Affiliations
Soon will be listed here.
Citing Articles

Factors associated with primary healthcare provider access among trans and non-binary immigrants, refugees, and newcomers in Canada.

Ghabrial M, Ferguson T, Scheim A, Adams N, Khatoon M, Bauer G J Migr Health. 2024; 10:100241.

PMID: 39040891 PMC: 11261874. DOI: 10.1016/j.jmh.2024.100241.


The double-edged sword of PCOS and gender: exploring gender-diverse experiences of polycystic ovary syndrome.

Wugalter K, Perovic M, Karkaby L, Einstein G Int J Transgend Health. 2024; 25(2):251-267.

PMID: 38681493 PMC: 11044764. DOI: 10.1080/26895269.2023.2183448.


Exploring Gender Diversity in Transgender and Non-Binary Adults Accessing a Specialized Service in Italy.

Mirabella M, Di Giannantonio B, Giovanardi G, Piras I, Fisher A, Lingiardi V Healthcare (Basel). 2023; 11(15).

PMID: 37570390 PMC: 10418792. DOI: 10.3390/healthcare11152150.


Body image and treatment desires at clinical entry in non-binary and genderqueer adults.

Huisman B, Verveen A, de Graaf N, Steensma T, Kreukels B Int J Transgend Health. 2023; 24(2):234-246.

PMID: 37114111 PMC: 10128456. DOI: 10.1080/26895269.2022.2131675.


Gender-Affirming Hormone Therapy for the Trans, Gender Diverse, and Nonbinary Community: Coordinating World Professional Association for Transgender Health and Informed Consent Models of Care.

Solanki P, Colon-Cabrera D, Barton C, Locke P, Cheung A, Spanos C Transgend Health. 2023; 8(2):137-148.

PMID: 37013095 PMC: 10066762. DOI: 10.1089/trgh.2021.0069.


References
1.
Pottern L, Brown L, Hoover R, Javadpour N, OConnell K, Stutzman R . Testicular cancer risk among young men: role of cryptorchidism and inguinal hernia. J Natl Cancer Inst. 1985; 74(2):377-81. View

2.
Kreukels B, Kohler B, Nordenstrom A, Roehle R, Thyen U, Bouvattier C . Gender Dysphoria and Gender Change in Disorders of Sex Development/Intersex Conditions: Results From the dsd-LIFE Study. J Sex Med. 2018; 15(5):777-785. DOI: 10.1016/j.jsxm.2018.02.021. View

3.
Aloia J, Vaswani A, Yeh J, Ross P, Flaster E, Dilmanian F . Calcium supplementation with and without hormone replacement therapy to prevent postmenopausal bone loss. Ann Intern Med. 1994; 120(2):97-103. DOI: 10.7326/0003-4819-120-2-199401150-00001. View

4.
Turner A, Chen T, Barber T, Malabanan A, Holick M, Tangpricha V . Testosterone increases bone mineral density in female-to-male transsexuals: a case series of 15 subjects. Clin Endocrinol (Oxf). 2004; 61(5):560-6. PMC: 3098904. DOI: 10.1111/j.1365-2265.2004.02125.x. View

5.
Van Caenegem E, Wierckx K, Taes Y, Schreiner T, Vandewalle S, Toye K . Body composition, bone turnover, and bone mass in trans men during testosterone treatment: 1-year follow-up data from a prospective case-controlled study (ENIGI). Eur J Endocrinol. 2015; 172(2):163-71. DOI: 10.1530/EJE-14-0586. View